Researchers led by a team at Massachusetts Eye and Ear have identified a novel cellular entry factor for adeno-associated virus vector (AAV) types—the most commonly used viral vectors for in vivo gene therapy. AAVs are ...
Jan 23, 2020
0
85
Ethiopia's second largest city, Dire Dawa, is dealing with a chikungunya fever outbreak. Around 20,000 cases of the mosquito-borne viral infection have been reported since the outbreak started in March 2019. This is the second ...
Sep 16, 2019
0
2
Overuse of insecticides, which leads to the selection of resistant mosquitoes, affects interactions between mosquitoes and the pathogens they transmit. Researchers from the Institut Pasteur (Paris) and its partners have now ...
Feb 1, 2019
0
0
Life in a single-family home in suburban America, one with a quiet and spacious backyard, surrounded by natural habitats, lush green vegetation, where beautiful birds, squirrels and other small mammals come and go, is the ...
Oct 22, 2018
0
0
India has reported an outbreak of the Zika virus with 80 confirmed cases since last month including 22 pregnant women in the western state of Rajasthan, officials said Wednesday.
Oct 17, 2018
0
3
As federal authorities weigh a plan to release genetically modified mosquitoes to help control the spread of the Zika virus, they need to overcome public fears about the risks and potential unintended consequences.
Jun 14, 2016
0
2
Hawaii Gov. David Ige declared a state of emergency to fight mosquito borne illnesses including dengue fever and the Zika virus.
Feb 13, 2016
0
4
In fall 2012, the European Medicines Agency (EMA) approved the modified adeno-associated virus AAV-LPL S447X as the first ever gene therapy for clinical use in the Western world. uniQure, a Dutch biotech company, had developed ...
Jun 19, 2013
0
0
Researchers from the RIKEN Brain Science Institute report that they successfully used a virus vector to restore the expression of a brain protein and improve cognitive functions, in a mouse model of Alzheimer's disease.
Apr 1, 2013
0
0
A promising new drug target for the treatment and prevention of heart failure has been discovered by researchers at Mount Sinai School of Medicine in New York, NY, US. The study was presented at the ESC Congress 2012 by principal ...
Aug 27, 2012
0
0
